We enclose the Unaudited Standalone and Consolidated Financial Results for the quarter ended
As filed · Outcome of Board Meeting
EarningsNotablemateriality 72 out of 100
What happened
FactWe enclose the Unaudited Standalone and Consolidated Financial Results for the quarter ended. Also enclosed herewith is the Limited Review Report of the Financial Results for the quarter ended. 30th June 2026 issued by the Company’s statutory auditors M/s B S R & Co. LLP, Chartered.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnEarlierQ4 FY26
we hope to do that and maybe do a bit better.
NowQ4 FY26
this preponement can keep happening because at each month you can keep advancing from the future because wedding dates are in a way sustained.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement expressed hope for better performance, while the current statement does not provide a specific target or expectation for demand. This indicates that a previously stated target is no longer being given.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- we hope to do that and maybe do a bit better. (management committed by FY27)
- We are committed to a double-digit healthy growth in value in the jewellery business. (management committed by FY30)
Evidence
- Titan Company Limited has submitted to the Exchange, Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026.(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%